Literature DB >> 16135997

Biochemical markers and genetic research of ADHD.

I Paclt1, J Koudelová, A Krepelová, P Uhlíková, M Gazdíková, P Bauer.   

Abstract

ADHD (attention hyperactivity disorder) is a polygenetic disorder with various candidate genes. At this time, more than thirty dopaminergic, noradrenergic, serotonergic and GABA-ergic genes are known. The research of only some candidate genes (DRD4, DAT, DRD5, DBH, 5HTT, HTR1B and SNAP25) brought relatively consistent results confirming the heredity of ADHD syndromes. The results of research of other genes (DRD2, DRD3, MAO, ADR2A, GABA A3, GABA B3) are not clear yet. This paper summarizes the most important genetic data in correlations with biochemical periphery parameters (especially for DBH, HVA, MHPG, serotonin). Hypothetically, certain subgroups of ADHD may be identified by correlation of biochemical characteristics and some candidate genes. The paper discusses some implications for future research. Review.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135997

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  3 in total

Review 1.  Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths.

Authors:  David E Comings; Thomas J H Chen; Kenneth Blum; Julie F Mengucci; Seth H Blum; Brian Meshkin
Journal:  Theor Biol Med Model       Date:  2005-12-23       Impact factor: 2.432

2.  Prevalence and assessment of biochemical parameters of attention-deficit hyperactivity disorder children in Bangladesh.

Authors:  Chowdhury Mohammad Monirul Hasan; Mohammad Monirul Islam; Muhammad Mamunur Rashid Mahib; Mahmud Ahmed Chowdhury Arju
Journal:  J Basic Clin Pharm       Date:  2016-06

3.  Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients.

Authors:  Frank Faltraco; Denise Palm; Adriana Uzoni; Lena Borchert; Frederick Simon; Oliver Tucha; Johannes Thome
Journal:  J Neural Transm (Vienna)       Date:  2021-07-18       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.